Study of Individualized Therapies Selection for Patients With Metastatic Colorectal Carcinoma According to the Therapeutic
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Metastatic Disease
Related studies linked through entity extraction aliases.
BIBW 2992 as add-on to Gem/Cis in Advanced Biliary Tract Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Study of AUY922 in Metastatic Pancreatic Cancer Who Are Resistant to First Line Chemotherapy
- Status
- TERMINATED
- Phase
- PHASE2
Study of Itraconazole in Castrate-resistant Prostate Cancer (CRPC) Post-chemotherapy
- Status
- TERMINATED
- Phase
- PHASE2
Trial of Tasigna (Nilotinib) 400 mg Twice Daily Alone or With Gleevec (Imatinib Mesylate) 400 mg Daily for Patients With Advanced Gastrointestinal Stromal Tumor (GIST)
- Status
- TERMINATED
- Phase
- PHASE2
Temsirolimus to Reverse Androgen Insensitivity for Castration-resistant Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study Using High-Dose Single Fraction Image-Guided Radiotherapy for Metastatic Lesions to Soft Tissue Masses, Lymph Node, or Bone
- Status
- COMPLETED
- Phase
- PHASE1
Study Comparing Association Between Sorafenib and Interleukin-2 (IL-2) Versus Sorafenib in 1st Line Therapy in Advanced (Adv) Renal Cell Carcinoma (RCC)
- Status
- COMPLETED
- Phase
- PHASE2
Evaluation of the Association Between CYP2D6 Genetic Polymorphisms and the Treatment Effect of Tamoxifen
- Status
- TERMINATED
- Phase
- PHASE2
Pre-operative Administration of Sorafenib in Patients With Metastatic Renal Cell Carcinoma Undergoing Kidney Removal
- Status
- COMPLETED
- Phase
- PHASE2
Melanoma Inhibitory Activity (MIA): A Serological Marker for Metastatic Uveal Melanoma
- Status
- UNKNOWN
- Phase
- N/A
Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain Tumors
- Status
- COMPLETED
- Phase
- PHASE3